Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine supra-inguinal fascia iliaca block for postoperative analgesia after total hip arthroplasty
ChiCTR2500096425Phase 4Completed
- Sponsor
- Dazhou Central Hospital
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of liposomal bupivacaine, bupivacaine, ropivacaine and dexamethasone in postoperative pain (2 arms), sponsored by Dazhou Central Hospital. Primary endpoint: Static and dynamic pain numerical rating scale scores. Started Jan 2025; status: completed.
02
Drugs
liposomal bupivacainebupivacaineropivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500096425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096425.